Bulimia Nervosa
📧 Sign up to get email alerts when something new happens for Bulimia Nervosa.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-20FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fluoxetine hydrochloride, enabling marketing of a generic fluoxetine produc…
-
FDA approval · 2021-09-01FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine hydrochloride from Dr. Reddy's Laboratories Limited (ANDA 078572), updating regulator…
-
FDA approval · 2021-08-31FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for fluoxetine from Saptalis Pharmaceuticals, confirming the availability of a generic fluoxetine pr…
-
FDA approval · 2021-08-27FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for a fluoxetine hydrochloride generic product from PAI Holdings (PAI Pharma). This action approves …
-
FDA approval · 2021-08-25FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for Fluoxetine from Dr. Reddy's Laboratories Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy [NA]
A completed clinical trial evaluating a mentorship/support group program for eating disorders with preliminary efficacy results posted.
-
FDA approval · 2021-04-19FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., updating the generic's labeling under the AN…
-
FDA approval · 2021-01-21FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine submitted by Alembic Pharmaceuticals Limited.
-
FDA approval · 2020-12-23FDA Approved: FLUOXETINE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for Fluoxetine from Cadila Pharmaceuticals Limited, enabling the marketing of this generic fluoxetin…
-
FDA approval · 2020-06-10FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic fluoxetine through an Original Application (ANDA).
-
FDA approval · 2020-04-28FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2020-04-08FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic fluoxetine product from Aurobindo Pharma Limited under an Original Application (ANDA 213286). Fluoxetine is an SSRI i…
-
FDA approval · 2019-10-29FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride product from Vensun Pharmaceuticals, thereby approving a generic vers…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD [NA]
Completed clinical trial evaluating effectiveness of prazosin for nightmares in patients with PTSD-related stress disorders and bulimia nerv…
-
FDA approval · 2019-05-23FDA Approved: FLUOXETINE — Original Application (Cadila Pharmaceuticals Limited)
Cadila Pharmaceuticals Limited received FDA approval for an original application of fluoxetine (generic).
-
FDA approval · 2019-04-15FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's original (generic) application for fluoxetine hydrochloride.
-
FDA approval · 2019-03-20FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved ScieGen Pharmaceuticals' original application for fluoxetine, authorizing the marketing of a generic fluoxetine product. Fluoxe…
-
FDA approval · 2019-02-08FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic fluoxetine hydrochloride under an original application (ANDA).
-
FDA approval · 2019-01-25FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (NorthStar Rx LLC)
FDA approved an original generic application for fluoxetine hydrochloride from NorthStar Rx LLC. Fluoxetine hydrochloride is used to treat m…
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls [NA]
A clinical trial update indicates that the study investigating neural responses to catecholamine depletion in individuals with a history of …
-
FDA approval · 2019-01-10FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original abbreviated new drug application for fluoxetine hydrochloride (generic fluoxetine), authorizi…
-
FDA approval · 2018-11-21FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA granted approval for the original application of a generic fluoxetine hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)
A biobehavioral study on bulimia nervosa sponsored by Drexel University has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: FDA Approved Medication to Reduce Binge Eating and/or Purging [Phase 1]
Phase 1 trial update noting the completion of a study evaluating an FDA-approved medication to reduce binge eating and/or purging. The study…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Testing an Alternative Therapy for Bulimia Nervosa [NA]
The document reports the completion of a clinical trial evaluating an alternative therapy for bulimia nervosa.